http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014053502-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_009354741f6fb60d742572075edf7564
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-665
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2013-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7090921ae4c8dac0efbd8f4592cd17d0
publicationDate 2014-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014053502-A1
titleOfInvention A method for predicting the risk of getting cancer or diagnosing cancer in a female subject
abstract Subject matter of the present invention is a method for predicting the risk of getting cancer in a female subject that does not suffer from cancer or alternatively diagnosing cancer in a female subject comprising: • determining the level of Pro-Enkephalin or fragments thereof including Leu-Enkephalin and Met-Enkephalin of at least 5 amino acids in a bodily fluid obtained from said female subject; and • correlating said level of Pro-Enkephalin or fragments thereof with a risk for getting cancer, wherein a reduced level is predictive for an enhanced risk of getting cancer or alternatively diagnosing cancer wherein an reduced level is correlated with the diagnosis of cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107430135-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016097781-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3002589-A1
priorityDate 2012-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008160557-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2293079-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005181375-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0353971-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226505755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226526054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226417679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID425562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6427062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57282044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413457

Total number of triples: 36.